Archive

Earlier capital markets commentary.

Pieces that have rolled off the live feed. The full back catalogue lives here.

Listing Pathway · 5 min read · Amanda Ooi

Bursa ACE or Nasdaq? How we pick, for an Asian growth company

Every Asian growth founder asks the same question in the first ten minutes: where should we list? The answer almost never is what they came in expecting. The three-lens framework we use.

operator-led engagement · 6 min read · Cynthia Ng

The investment screening conversation: five things we look at first

Before we recommend anything, we diagnose. Five questions we work through in the first 30 minutes with any founder, and what each one tells us about listing readiness.

IPO Pathway · 7 min read

What founders should know about Nasdaq listing standards in 2026

The bar has quietly moved. Round-lot shareholder thresholds, free-float requirements, and minimum price tests now matter more than they did three years ago, and the gap between "Asian growth story" and "U.S. listing-ready" is wider than most pre-IPO decks admit.

Capital Structure · 5 min read

How structured capital differs from traditional VC for pre-IPO companies

Pre-IPO companies don't always need another priced equity round. Redeemable preference shares, convertible bridges, and structured-yield programs often deliver the same runway without diluting the founders or jamming up the cap table before listing day.

Post-IPO Governance · 8 min read

The post-IPO governance playbook: lessons from a regional listing

Listing day is a milestone, not the finish line. The first 24 months as a public company, including board cadence, audit-committee discipline, IR strategy, and the way you handle your first quarterly comment from the SEC or local regulator, quietly determines whether your re-rating happens at all.